1. Home
  2. DEFT vs ARDX Comparison

DEFT vs ARDX Comparison

Compare DEFT & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DEFT
  • ARDX
  • Stock Information
  • Founded
  • DEFT 1986
  • ARDX 2007
  • Country
  • DEFT Canada
  • ARDX United States
  • Employees
  • DEFT N/A
  • ARDX N/A
  • Industry
  • DEFT
  • ARDX Biotechnology: Pharmaceutical Preparations
  • Sector
  • DEFT
  • ARDX Health Care
  • Exchange
  • DEFT NYSE
  • ARDX Nasdaq
  • Market Cap
  • DEFT 973.0M
  • ARDX 882.9M
  • IPO Year
  • DEFT N/A
  • ARDX 2014
  • Fundamental
  • Price
  • DEFT $2.89
  • ARDX $4.29
  • Analyst Decision
  • DEFT Strong Buy
  • ARDX Strong Buy
  • Analyst Count
  • DEFT 2
  • ARDX 9
  • Target Price
  • DEFT $6.25
  • ARDX $10.17
  • AVG Volume (30 Days)
  • DEFT 5.0M
  • ARDX 4.3M
  • Earning Date
  • DEFT 05-14-2025
  • ARDX 08-04-2025
  • Dividend Yield
  • DEFT N/A
  • ARDX N/A
  • EPS Growth
  • DEFT N/A
  • ARDX N/A
  • EPS
  • DEFT 0.05
  • ARDX N/A
  • Revenue
  • DEFT $85,431,816.00
  • ARDX $361,706,000.00
  • Revenue This Year
  • DEFT $313.68
  • ARDX $11.39
  • Revenue Next Year
  • DEFT $28.27
  • ARDX $32.84
  • P/E Ratio
  • DEFT $57.99
  • ARDX N/A
  • Revenue Growth
  • DEFT 631.90
  • ARDX 127.33
  • 52 Week Low
  • DEFT $2.54
  • ARDX $3.21
  • 52 Week High
  • DEFT $4.95
  • ARDX $7.18
  • Technical
  • Relative Strength Index (RSI)
  • DEFT N/A
  • ARDX 51.49
  • Support Level
  • DEFT N/A
  • ARDX $4.27
  • Resistance Level
  • DEFT N/A
  • ARDX $4.48
  • Average True Range (ATR)
  • DEFT 0.00
  • ARDX 0.19
  • MACD
  • DEFT 0.00
  • ARDX -0.03
  • Stochastic Oscillator
  • DEFT 0.00
  • ARDX 15.84

About DEFT DEFI TECHNOLOGIES INC

DeFi Technologies Inc is a Canadian technology company bridging the gap between traditional capital markets and decentralized finance. The Company generates revenues through the issuance of exchange-traded products that synthetically track the value of a single DeFi protocol, investments in various companies and leading protocols across the decentralized finance ecosystem to build a diversified portfolio of decentralized finance assets, providing premium membership for research reports to investors and offering node management of decentralized protocols to support governance, security and transaction validation.

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Share on Social Networks: